Marrone Bio Innovations

Marrone Bio Innovations, Inc., a biopesticide company, engages in the discovery, development, and marketing of natural products for weed, pest, and plant disease management. Its products include Regalia, a product that protects food and ornamental crops from fungal and bacterial diseases; GreenMatch EX, a postemergence herbicide for burndown weed control for organic growers; and GreenMatch, a burndown herbicide that controls various annual and perennial weeds. The Company also offers insecticides, herbicides, and products for controlling invasive zebra and quagga mussels in waterways. In addition, it finds naturally occurring microorganisms from habitats and develops them into products for controlling insects, weeds, nematodes, and plant diseases.

Company Growth (employees)
Type
Public
HQ
Davis, US
Founded
2006
Size (employees)
97 (est)+13%
Marrone Bio Innovations was founded in 2006 and is headquartered in Davis, US

Key People/Management at Marrone Bio Innovations

Pam Marrone

Pam Marrone

Founder and CEO
Keith Pitts

Keith Pitts

Vice President, Regulatory Affairs

Marrone Bio Innovations Office Locations

Marrone Bio Innovations has an office in Davis
Davis, US (HQ)
2121 Second St.
Davis, US
1540 Drew Ave
Show all (2)

Marrone Bio Innovations Financials and Metrics

Marrone Bio Innovations Financials

Marrone Bio Innovations's revenue was reported to be $14 m in FY, 2016
USD

Revenue (Q3, 2017)

4.2 m

Net income (Q3, 2017)

(8.5 m)

EBIT (Q3, 2017)

(6.6 m)

Market capitalization (22-Dec-2017)

33.9 m

Cash (30-Sep-2017)

3.7 m

EV

31.8 m
Marrone Bio Innovations's current market capitalization is $33.9 m.
USDFY, 2013Y, 2014FY, 2015FY, 2016

Revenue

14.5 m1.1 m9.8 m14 m

Revenue growth, %

(92%)793%43%

General and administrative expense

18.5 m

Operating expense total

18.5 m
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.3 m2.8 m3.6 m2.1 m3.4 m2.5 m2.7 m5 m3.6 m4.2 b6.5 b4.2 m

R&D expense

4.5 m

General and administrative expense

4.5 m6.3 m6 m7.9 m7.4 m5.3 m5.5 m4.5 m3.8 m5.3 b5.1 b5.2 m

Operating expense total

8.9 m10.6 m10.3 m11.3 m10.7 m8.8 m7.9 m6.8 m6.4 m7.8 b7.9 b8.3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

24.5 m35.3 m19.8 m9.6 m

Accounts Receivable

6.2 m1.8 m2.3 m3.6 m

Inventories

1.7 m1.3 m1.3 m8.5 m

Current Assets

58.7 m54.7 m36 m26.9 m
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

40.8 m21.3 m57.6 m22.4 m12.2 m27.8 m9.8 m21.2 m16 m1.8 m10.2 m3.7 m

Accounts Receivable

2.1 m7.2 m4.1 m2.2 m3 m1.4 m4.7 m4.5 m2.1 m8.1 m5.8 m1.9 m

Inventories

10.8 m12.8 m12.5 m11.8 m10.6 m9.8 m8.6 m8 m8.4 m8.1 m8.4 m9.3 m

Current Assets

68.6 m47 m80.1 m41.1 m30.2 m43.4 m28.1 m37.8 m30.6 m24.4 m29.6 m19.5 m
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    (28.5 m)(16.2 m)(43.7 b)(31.1 m)

    Depreciation and Amortization

    976 k2.2 m

    Accounts Receivable

    (3.4 m)1.8 m(1.2 m)

    Inventories

    (6.8 m)1.3 m582 k
    USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

    Net Income

    (6.1 m)(10.2 m)(10.4 m)(11.9 m)(22.9 m)(32.7 m)(9.3 m)(16.1 m)(23.3 m)(7.6 b)

    Depreciation and Amortization

    833 k1.7 m2.6 m594 k1.2 m1.7 m

    Accounts Receivable

    7.2 m4.1 m(383 k)(1.2 m)398 k(2.3 m)(2.2 m)292 k8.1 m

    Inventories

    869 k2 m2.9 m504 k1.1 m659 k
      Y, 2017

      EV/EBIT

      -4.8 x

      Financial Leverage

      -0.9 x
      Show all financial metrics

      Marrone Bio Innovations Market Value History

      Marrone Bio Innovations's Web-traffic and Trends

      Marrone Bio Innovations Online and Social Media Presence

      Marrone Bio Innovations Company Life and Culture

      You may also be interested in